Skip to main content

Traci McCarty

Head of Investor Relations

Biomarin Pharmaceutical Inc (BMRN)

Equibles does not estimate personal net worth.

Get an email with a short summary when Biomarin Pharmaceutical Inc publishes a filing, an earnings call transcript or a press release.

Get BMRN alerts

About Traci McCarty

Traci McCarty is recorded as Head of Investor Relations at Biomarin Pharmaceutical Inc (BMRN). Traci McCarty has spoken on 26 earnings calls across 1 company, most recently for Biomarin Pharmaceutical Inc on November 2, 2026. Biomarin Pharmaceutical Inc is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Biomarin Pharmaceutical Inc includes Alexander Hardy (CEO and Board Member), Richard A. Meier (Chairman), Brian Mueller (CFO) and 7 others.

Traci McCarty on recent calls

“To remind you, this non-confidential presentation contains forward-looking statements about the business prospects of Biomarin Pharmaceutical, Inc., including expectations regarding Biomarin's financial performance, commercial products, and potential future products in different areas of therapeutic research and…”
Head of Investor Relations, BioMarin Pharmaceutical Third Quarter 2026 Conference Call ·
“To remind you, this non-confidential presentation contains forward-looking statements about the business prospects of BioMarin Pharmaceutical, Inc., including expectations regarding BioMarin's financial performance, commercial products, and potential future products in different areas of therapeutic research and…”
Head of Investor Relations, BioMarin Pharmaceutical Second Quarter 2026 Conference Call ·
“And starting on slide two, to remind you, this non-confidential presentation contains forward-looking statements about the business prospects of BioMarin Pharmaceutical, Inc., including expectations regarding BioMarin's financial performance, commercial products, and potential future products in different areas of…”
Head of Investor Relations, Biomarin Pharmaceutical Inc Q4 FY2025 Earnings Call ·
“To remind you, this non-confidential presentation contains forward-looking statements about the business prospects of BioMarin Pharmaceutical, Inc., including expectations regarding BioMarin's financial performance, commercial products, and potential future products in different areas of therapeutic research and…”
Head of Investor Relations, Biomarin Pharmaceutical Inc Q3 FY2025 Earnings Call ·

Affiliation history

Company network

Leadership on record at Biomarin Pharmaceutical Inc

Recent activity

Show 14 earlier activities